You need the right data at the right time from your supplier to make important production and supply chain decisions to achieve your Biopharma Manufacturing goals. Now you have the eMERGE™ Program, our standard platform for the exchange of electronic data. It provides key raw material data, electronically, for every shipment, so you can start making informed decisions right away.
Thursday, June 17, 2021 Daily Archives
Vero Cell-based Vaccine Production: Cell lines, Media and Bioreactor Options
The recent Covid-19 pandemic introduced new challenges for the vaccine industry, it has also brought in new innovations in vaccine development including DNA/RNA based vaccines. The pandemic also increased the demand for well-established cell-based vaccine production technologies. The article reviews strategies for optimizing Vero cell-based vaccine production using rabies and influenza as examples. The Vero cell line is one of the most satisfactory vaccine production hosts based on its infectability, stability and well-documented performance in quality and quantity of viral…
Dendreon leveraging Provenge network to launch cell therapy CDMO biz
Dendreon says its experience bringing Provenge to market puts it in good stead to offer its process development, manufacturing, and patient logistics capabilities to other cell therapy makers. Dendreon has had a turbulent past. Its autologous cell therapy product Provenge (sipuleucel-T) was approved in the US in 2010 for the treatment of prostate cancer but manufacturing complexities and costs led the firm to restructure itself in 2012, including selling its Morris Plains, New Jersey to Novartis. Then in 2014 Dendreon…
Jubilant HollisterStier $92m fill/finish expansion, wins Ocugen Covaxin contract
CDMO Jubilant HollisterStier will supply Indian COVID-19 vaccine Covaxin from its sterile injectable site in Spokane, Washington, currently undergoing a capacity expansion. Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is a highly purified and inactivated vaccine manufactured using a vero cell manufacturing platform. Philadelphia-based biotech Ocugen is working with Bharat to bring the vaccine in Canada and the US and has selected contract development and manufacturing organization (CDMO) Jubilant HollisterStier to help…